Julius-Maximilians University
Also known as: Chairman Dept. of Periodontology, University Hospital Wuerzburg, Germany | Children's Hospital, University Medical Center Göttingen | Department of Dermatology, University of Wuerzburg, Germany | Department of Internal Medicine, University of Wuerzburg, Germany | Department of trauma, hand, reconstructive and plastic, University of Wuerzburg | Dept of Dermatology, University of Wuerzburg | Dept. of Internal Medicine II, University of Wuerzburg | Dept. of Internal Medicine II, University of Wuerzburg, Klinikstr. 6-8, 97070 Wuerzburg | Dept. of Internal Medicine, University of Wuerzburg | Universitaets-Hautklinik Wuerzburg | Universitaets - Kinderklinik Wuerzburg | Universitätsklinikums Würzburg | University Hospital Wuerzburg | University Hospital Wuerzburg- Departement of Medicine II | University Hospital Wuerzburg, Germany | University of Würzburg | University of Wuerzburg | University of Wuerzburg. Department of Endocrinology | University of Wuerzburg Medical Centre, Department of Internal Medicine II | Würzburg University Hospitals | Wuerzburg University | Wuerzburg University Hospital | Wuerzburg University Hospital, Dept. of Hematology and Oncology | Wuerzburg University Hospital, Dept. of Internal Medicine II
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2000Last known activity
Jul 31, 2026
Timeline
1400s
- Jan 1, 1402
Julius-Maximilians University— Founded
Drugs by trial phase (88 distinct, 61 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (34 own, 0 via acquisition)
Phase 2 (21 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (21 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Acromegaly
- Addison Disease
- Adrenal Gland Neoplasms
- Adrenal Insufficiency
- Adrenocortical Carcinoma
- Anemia, Aplastic
- Atrial Fibrillation
- Attention Deficit Disorder with Hyperactivity
- Carcinoma
- Cerebral Hemorrhage
- Disease Progression
- Edema
- Familial Hypophosphatemic Rickets
- Fibromyalgia
- Glioblastoma
- Glioma
- Heart Failure
- Hemorrhage
- HIV Infections
- Hodgkin Disease
- Hypertrophy
- Hypertrophy, Left Ventricular
- Hypophosphatemia
- Kidney Diseases
- Kidney Failure, Chronic
- Kidney Neoplasms
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lymphoma
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Melanoma
- Multiple Myeloma
- Mycoses
- Myelodysplastic Syndromes
- Myofascial Pain Syndromes
- Neoplasms, Plasma Cell
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Schizophrenia
- Sepsis
- Syndrome
- Uterine Cervical Neoplasms
- Uveal Neoplasms
- Waldenstrom Macroglobulinemia
Recent trials (50)
- NCT07153289CollaboratorPhase 1/Phase 2Jul 31, 2026
- NCT06137378CollaboratorPhase 2Nov 30, 2024
- NCT06163573CollaboratorPhase 2Apr 30, 2024
- NCT06216158CollaboratorPhase 3Apr 5, 2024
- NCT06279793OfficialPhase 2Feb 15, 2024
- NCT06279793CollaboratorPhase 2Feb 15, 2024
- NCT06090851Reponsible party - principal investigatorN/ASep 15, 2023
- NCT06090851Lead sponsorN/ASep 15, 2023
- NCT05820841CollaboratorPhase 3Jun 7, 2023
- NCT05698680CollaboratorPhase 4Jan 18, 2023
- NCT05638633Lead sponsorPhase 3Nov 11, 2022
- NCT04695860Overall official - principal investigatorPhase 3Dec 31, 2021
- NCT04695860Lead sponsorPhase 3Dec 31, 2021
- NCT04633148Overall official - principal investigatorPhase 1Nov 16, 2020
- NCT04499339Study directorPhase 1/Phase 2Jul 22, 2020
Details
- Founded
- Wurzburg, DE Jan 1, 1402
- Last known activity
- Jul 31, 2026